HSDT (HSDT) Stock Price & Analysis
HSDT (HSDT) fell 0.22% to USD 2.24 as of September 8, 2026 at 16:20 UTC, according to Nexqual real-time market data.
HSDT last closed at USD 2.24; the session ranged USD 2.2–2.29 on volume of 155,079 shares. Market capitalization is —, with a 52-week range of USD 1.19–25.5 (NCM). Source: Nexqual, September 8, 2026 at 16:20 UTC.
Key Statistics (as of September 8, 2026 at 16:20 UTC)
| Price | USD 2.24 |
|---|---|
| Change | ▼ 0.22% (down) |
| Previous Close | USD 2.24 |
| Open | USD 2.24 |
| Day Range | USD 2.2 – 2.29 |
| 52-Week Range | USD 1.19 – 25.5 |
| Volume | 155,079 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (HSDT)
Nexqual's technical model rates HSDT "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 8, 2026 at 16:20 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.96 (neutral) |
| vs SMA50 | Above (USD 1.84) |
| MACD | 0.13 (positive) |
From HSDT's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHIO | Phio Pharmaceuticals Corp. | USD 1.03 | ▼ 7.03% |
| SPRC | SciSparc Ltd. | USD 5.19 | ▲ 1.17% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 7.21 | ▼ 8.39% |
| NUWE | Nuwellis, Inc. | USD 0.81 | ▲ 10.27% |
| ADIL | Adial Pharmaceuticals, Inc | USD 6.83 | ▲ 2.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:20 UTC. This page is informational and not investment advice.